Retatrutide 40mg | R&D Only

Retatrutide 40mg UK availability is one of the most common research queries we receive — this page covers everything you need before ordering, including mechanism, purity testing, and storage guidance.

What Is Retatrutide?

Retatrutide is a synthetic triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This 40mg vial is a higher-concentration format of the same research compound available in our 10mg and 20mg listings, intended for R&D protocols requiring a larger total quantity per vial — reducing the number of reconstitution cycles needed across an extended study.

ApexPure supplies Retatrutide 40mg strictly for R&D and laboratory research purposes, manufactured as a lyophilised, research-grade compound. The addition of glucagon receptor agonism alongside GIP and GLP-1 activity is the key research variable distinguishing this compound from earlier incretin-class peptides.

Research Applications

This compound is referenced in emerging metabolic research literature exploring multi-pathway energy expenditure and glucose-regulation models, extending beyond the dual-agonist research class represented by Tirzepatide. Researchers are particularly interested in whether glucagon receptor engagement contributes additional energy-expenditure effects alongside the appetite and glucose-regulation research already established for GIP/GLP-1 agonists. The 40mg format is often selected for longer-running R&D protocols or comparative studies requiring consistent material across multiple research sessions without reconstituting a new vial each time.

Background & Research History

Retatrutide represents the latest stage in a research progression that began with single-target GLP-1 agonists, advanced to dual GIP/GLP-1 agonists such as Tirzepatide, and has now extended to triple-receptor agonism. Its development reflects ongoing research interest in whether combining additional metabolic receptor pathways produces further research benefits beyond dual-agonist compounds. See our GLP-1 Research Peptides Explained guide for a full comparison against Semaglutide and Tirzepatide.

Purity & Third-Party Testing

Each batch of this 40mg vial is independently HPLC-verified to a minimum of 99% purity, with a downloadable Certificate of Analysis matched to the specific batch, available on this product listing. Every concentration in our Retatrutide range — 10mg, 20mg, and 40mg — is held to exactly the same testing threshold, regardless of R&D scale.

Reconstitution & Storage Guidelines

Keep the lyophilised vial frozen at -18°C or below, shielded from light. Once reconstituted, refrigerate at 2-8°C and avoid repeated freeze-thaw cycles to preserve this multi-mechanism compound’s stability. Given the higher total quantity in this format, R&D teams running extended protocols should pay particular attention to consistent reconstitution volume across sessions to maintain accurate concentration calculations.

Handling Notes for Researchers

Retatrutide 40mg should be handled only by qualified laboratory personnel using appropriate PPE, following institutional protocols for reconstitution, storage, and disposal. This product is not supplied for human use of any kind and is intended strictly for R&D applications.

Why Buy Retatrutide 40mg UK From ApexPure

ApexPure was built around one standard: every batch we sell is independently tested before it reaches your laboratory, and every Certificate of Analysis is published, not hidden behind a support request. This 40mg format is popular with laboratories running longer or higher-volume Retatrutide R&D protocols, and we test it to exactly the same independent HPLC standard as every other compound in our Weight Management range. Orders are dispatched from the UK, so researchers avoid the customs delays and cold-chain uncertainty that come with importing from overseas suppliers. If a batch does not meet our purity threshold, it does not go on sale — that is the certification promise behind the ApexPure name. Read more about our testing process, or check our FAQ for common questions about ordering and dispatch.

Frequently Asked Questions

How does the 40mg vial compare to the 10mg and 20mg versions?
All three are the same research compound at the same purity standard — they differ only in total quantity per vial, letting R&D teams choose based on protocol scale and reconstitution frequency.

Is Retatrutide 40mg tested to the same standard as other concentrations?
Yes. Every batch, regardless of concentration, is independently HPLC-verified to a minimum of 99% purity with a matched Certificate of Analysis.

Is this compound licensed for clinical use in the UK?
No — Retatrutide is supplied by ApexPure exclusively as an unlicensed research chemical for R&D and laboratory investigation, with no therapeutic claims made.

This product is sold strictly for laboratory and in-vitro research (R&D) use only. It is not a drug, food, supplement, or cosmetic, and is not intended for human or veterinary consumption, diagnostic, or therapeutic use. Not for use in humans or animals. Purchaser must be 18+ and confirms this material will be handled only by qualified researchers in a controlled laboratory setting, in accordance with UK law.